NDSL 1,951 Link page¿¡¼­ [¿ø¹®º¸±â] ¹öưÀ» Ŭ¸¯Çϼ¼¿ä.

[±¹³» ÇÐÀ§³í¹®]

DMAP1(Dnmt1-associated protein1)Àº DNMT1 °áÇÕ ´Ü¹éÁú·Î óÀ½ µ¿Á¤µÇ¾úÀ¸¸ç, ¿°»öÁú ¼ö½ÄÈ­¸¦ ÅëÇØ À¯ÀüÀÚ ¹ßÇö Á¶Àý¿¡ °ü¿©ÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¾ú´Ù(Rountree et al., 2000). ¶ÇÇÑ DMAP1-DNMT1 º¹ÇÕü´Â p33ING1-Sin3-HDAC º¹ÇÕü¿Í »óÈ£ÀÛ¿ëÇÏ¿© µ¿¿øÃ¼ ÁÖÀ§ÀÇ ¿°»öÁúÀ» ÀÌÁú¿°»öÁú ±¸Á¶·Î À¯Áö½ÃÄÑÁÖ¸ç, ¼¼Æ÷ÁÖ±â S±â ÈĹݿ¡ È÷½ºÅæ ¼ö½ÄÈ­¸¦ °¡Á®¿Â´Ù(Xin et al., 2004). DMAP1Àº ¼¼Æ÷ÁÖ±â S±â µ¿¾È DNMT1°ú °áÇÕÇÏ¿© Àü»ç¾ïÁ¦ ±â´ÉÀ» ³ªÅ¸³»¸ç, S±â ÈÄ¹Ý µ¿¾È¿¡´Â HDAC2¿Í DNMT1°ú ÇÔ²² DNA º¹Á¦Á¡¿¡ °áÇÕÇÏ¿© Àü»ç¾ïÁ¦¼º ¿°»öÁúÀ» Çü¼ºÇÑ´Ù(Rountree et al., 2000). ¶ÇÇÑ DMAP1Àº NuA4/Tip60 È÷½ºÅæ ¾Æ¼¼Æ¿È­È¿¼Ò(HAT) º¹ÇÕü ¹× ATP-ÀÇÁ¸Àû Å©·Î¸¶Æ¾ ¸®¸ðµ¨¸µ º¹ÇÕü Swr1/SRCAPÀÇ Çٽɱ¸¼º¿øÀ¸·Î¼­ Àü»ç, DNA ¼Õ»ó¿¡ ´ëÇÑ ¼¼Æ÷¹ÝÀÀ ¹× ¼¼Æ÷ÁÖ±â Á¶Àý¿¡ °ü¿©ÇÏ´Â °ÍÀ¸·Î ¹àÇôÁ³´Ù(Doyon et al., 2004, Jin et al., 2005). º» ¿¬±¸½Ç¿¡¼­ »ýÁã ¹è¾ÆÁٱ⠼¼Æ÷ÁַκÎÅÍ »õ·Î¿î À¯ÀüÀÚ·Î µ¿Á¤ÇÑ MAT1 ÀÇÁ¸Àû Àü»ç ¾ïÁ¦ÀÎÀÚ(Mat1-mediated transcriptional repressor: MMTR)´Â DMAP1°ú µ¿ÀÏÇÑ À¯ÀüÀÚÀÌ´Ù. MMTRÀº HDAC1(histone deacetylase 1)°ú Àü»çÁ¶ÀýÀÎÀÚ TFIIH º¹ÇÕüÀÇ ÇÑ ±¸¼º¿ä¼ÒÀÎ MAT1°ú °áÇÕÇÏ¿© Àü»ç¾ïÁ¦ ±â´ÉÀ» ³ªÅ¸³½´Ù(Kang et al., 2007). ¶ÇÇÑ MMTRÀº ¼¼Æ÷Áֱ⿡ µû¶ó ¹ßÇö¾çÀÇ º¯È­¸¦ º¸À̸ç, TFIIH º¹ÇÕüÀÇ ±¸¼º¿ä¼ÒÀÎ CAK º¹ÇÕü¿Í »óÈ£ÀÛ¿ëÇÔÀ¸·Î½á G1/S ¹× G2/M ±â¿¡¼­ ¼¼Æ÷Áֱ⸦ ¾ïÁ¦ÇÏ´Â ¼¼Æ÷³»À缺 À½¼º ¼¼Æ÷ÁÖ±â Á¶ÀýÀÎÀÚ·Î ÀÛ¿ëÇÔÀ» ¹àÇû´Ù(Shin et al., 2010) . µû¶ó¼­ MMTR/DMAP1Àº ´Ù¾çÇÑ ±âÀÛ¿¡ ÀÇÇØ ¼¼Æ÷Ȱµ¿À» Á¶ÀýÇÒ °ÍÀ¸·Î ÆÇ´ÜµÇÁö¸¸, ¾î¶»°Ô MMTRÀÌ ÀÌ·¯ÇÑ ´Ù¾çÇÑ ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ±âÀÛÀº ¾Ë·ÁÁø ¹Ù ¾ø´Ù. º» ¿¬±¸¿¡¼­´Â MMTRÀÌ »ýÁã ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¿î¸íÁ¶Àý¿¡ ¾î¶°ÇÑ ¿ªÇÒÀ» ÇÏ´ÂÁö ºÐ¼®ÇϰíÀÚ ÇÏ¿´´Ù. MMTR ¹ßÇö°¨¼â ¹× °ú¹ßÇö »ýÁã ¹è¾ÆÁٱ⼼Æ÷ÁÖ¸¦ °¢°¢ Á¦Á¶ÇÏ¿© ÀÚ°¡ºÐ¿­´É°ú ºÐÈ­´É¿¡ ¹ÌÄ¡´Â MMTRÀÇ ¿ªÇÒÀ» Á¶»çÇÑ °á°ú, µÎ ¼¼Æ÷ÁÖ ¸ðµÎ¿¡¼­ ÀÚ°¡ºÐ¿­´ÉÀº ´ëÁ¶±º ¼¼Æ÷¿Í À¯»çÇÏ¿´Áö¸¸, ºÐÈ­À¯µµ ½Ã ´ëÁ¶±º ¼¼Æ÷ Äݷδϴ ¸ðµÎ ºÐÈ­ÇÑ ¹Ý¸é MMTR ¹ßÇöÀÇ º¯È­°¡ ÀÖ´Â ¼¼Æ÷ÁÖÀÇ °æ¿ì ÀϺΠ¼¼Æ÷ ÄݷδÏ(20%)´Â ¹ÌºÐÈ­¸¦ À¯ÁöÇÏ¿´À¸¸ç ³ª¸ÓÁö´Â ºÐÈ­Ãʱ⿡ ¼¼Æ÷»ç°¡ À¯¹ßµÇ¾ú´Ù. º» °á°ú´Â ¹è¾ÆÁٱ⼼Æ÷ÀÇ Ãʱ⠺ÐÈ­°úÁ¤¿¡¼­ MMTR ´Ü¹éÁú ¾çÀÌ Àû´çÇÏ°Ô À¯ÁöµÇ¾î¾ß Çϸç, MMTRÀº ´Ù¾çÇÑ ÀÛ¿ë ±âÀÛÀ» ÅëÇÏ¿© ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¿î¸íÁ¶Àý¿¡ °ü¿©ÇÒ °ÍÀÓÀ» ½Ã»çÇÑ´Ù. MMTR¿¡ ÀÇÇÑ ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¿î¸íÁ¶Àý¿¡ ´ëÇÑ ºÐÀÚ ±âÀÛÀ» ¾Ë¾Æº¸±â À§ÇÏ¿© ¹ÌºÐÈ­(d0) ¹× ºÐÈ­À¯µµ ÈÄ 3Àϰ(d3)ÀÇ ´ëÁ¶±º, MMTR ¹ßÇö°¨¼â ¹× °ú¹ßÇö ¹è¾ÆÁٱ⼼Æ÷ÁÖ¸¦ ´ë»óÀ¸·Î ¸¶ÀÌÅ©·Î¾î·¹À̸¦ ¼öÇàÇÏ¿© ¹ßÇö º¯È­¸¦ º¸ÀÌ´Â À¯ÀüÀÚµéÀ» ºÐ¼®ÇÏ¿´´Ù. ¿¹ÃøÇÑ ´ë·Î µÎ ¼¼Æ÷ÁÖ¿¡¼­ ¹ßÇö º¯È­¸¦ º¸ÀÌ´Â À¯ÀüÀÚÀÇ ¹ßÇö ¾ç»óÀº ´Ü¼øÇÑ ¾ç¼º ȤÀº À½¼º »ó°ü°ü°è¸¦ ³ªÅ¸³»Áö ¾Ê°í, ¹ÌºÐÈ­ ¹× ºÐÈ­¼¼Æ÷¿¡¼­ °¢°¢ 4 ±×·ìÀ¸·Î ºÐ·ùµÇ¾úÀ¸¸ç ºÐÈ­¿Í ¹ÌºÐÈ­ °úÁ¤À» ÅëÇÕÇÒ °æ¿ì 16 ±×·ìÀ¸·Î ´ëº°µÇ¾ú´Ù. µû¶ó¼­ ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¿î¸íÁ¶Àý¿¡ À־ MMTRÀº MMTR ÀÇÁ¸Àû ȤÀº ºñÀÇÁ¸ÀûÀ¸·Î ´Ù¸¥ ´Ü¹éÁúµé°ú ´Ù¾çÇÑ º¹ÇÕü¸¦ Çü¼ºÇÏ¿© Àü»ç¾ïÁ¦ ȤÀº Àü»çȰ¼ºÀ» ³ªÅ¸³»¸ç, MMTR ¹ßÇö°¨¼â ¹× °ú¹ßÇö ¹è¾ÆÁٱ⼼Æ÷ÁÖ¿¡¼­ÀÇ Ãʱ⠺ÐÈ­ ÀúÇØ´Â ÀÌ·¯ÇÑ ´Ù¾çÇÑ º¹ÇÕüµéÀÇ ºñÁ¤»óÀû ÀÛ¿ë¿¡ ÀÇÇÑ À¯ÀüÀû ºÒ±ÕÇü¿¡ ±âÃÊÇÒ °ÍÀ¸·Î ¿¹ÃøÇÒ ¼ö ÀÖ¾ú´Ù. ±×·¯³ª ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ºÐ¼®¿¡¼­ ¹ßÇöº¯È­¸¦ º¸ÀÌ´Â À¯ÀüÀÚ´Â MMTR¿¡ ÀÇÇØ Á÷Á¢ ȤÀº °£Á¢ÀûÀ¸·Î ¿µÇâÀ» ¹ÞÀº À¯ÀüÀÚµéÀ̹ǷÎ, MMTRÀÇ Á÷Á¢ÀûÀΠǥÀû À¯ÀüÀÚµéÀ» ´ë»óÀ¸·Î MMTR °áÇմɰú À¯ÀüÀÚ ¹ßÇö º¯È­ ¾ç»óÀ» ºÐ¼®ÇÒ Çʿ䰡 ÀÖ´Ù. ÀÌ¿¡ µû¶ó ¹ÌºÐÈ­(d0), ºÐÈ­ 2.5 Àϰ(d2.5) ¹× ºÐÈ­ 3Àϰ(d3) »ýÁã ¹è¾ÆÁٱ⼼Æ÷ÁÖ¸¦ ´ë»óÀ¸·Î ChIP-Chip ¹× ChIP-sequencing À» ¼öÇàÇÏ¿© À¯Àüü ¼öÁØ¿¡¼­ MMTRÀÇ °áÇÕºÎÀ§¸¦ µ¿Á¤ÇÑ ÈÄ, Ç¥Àû À¯ÀüÀÚ¿¡ ´ëÇÏ¿© MMTR °áÇÕ ¿©ºÎ¿Í À¯ÀüÀÚ ¹ßÇö ¾ç»ó°úÀÇ ¿¬°ü¼ºÀ» ºÐ¼®ÇØ º¸¾Ò´Ù. MMTRÀº ´ëºÎºÐÀÇ Ç¥Àû À¯ÀüÀÚ¿¡¼­ Àü»ç °³½ÃÁ¡À» Áß½ÉÀ¸·Î 1kb À̳»¿¡ °áÇÕÇÏ¿´À¸¸ç, MMTR Ç¥Àû À¯ÀüÀÚ Áß¿¡´Â ¹ß»ý/ºÐÈ­ °ü·Ã À¯ÀüÀÚ°¡ °¡Àå ¸¹¾Ò´Ù. ¶ÇÇÑ MMTR Ç¥Àû À¯ÀüÀÚÀÇ 40-50%´Â Àü»çÀÎÀÚ E2f1, Zfx, Myc, Rex ¹× Klf4 ÀÇ Ç¥Àû À¯ÀüÀÚÀ̾úÀ¸³ª, Pou5f1(Oct3/4), Nanog, Sox2 µîÀÇ ÇÙ½É Áٱ⼼Æ÷ÀÎÀÚ ¸ðµâ ¹× Suz12¿Í °°Àº polycomb ¸ðµâ°ú´Â Ç¥Àû À¯ÀüÀÚ¸¦ °øÀ¯ÇÏÁö ¾Ê¾Ò´Ù. µû¶ó¼­ MMTRÀº ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¹ÌºÐÈ­ À¯Áö¿¡ À־ ´ëºÎºÐ Myc ¸ðµâ À¯ÀüÀÚ¿Í ÇÔ²² ±â´ÉÇÔÀ» À¯ÃßÇÒ ¼ö ÀÖ¾ú´Ù. ¹ÌºÐÈ­¼¼Æ÷¿¡¼­ MMTR°ú °áÇÕÀ» ³ªÅ¸³»´ø °áÇÕºÎÀ§´Â ºÐÈ­(d2.5 ¹× d3.0)°¡ ÁøÇàµÊ¿¡ µû¶ó ´ëºÎºÐ °áÇÕ´ÉÀÌ °¨¼ÒÇÏ¿´À¸¸ç, ÀÌ¿¡ µû¸¥ Ç¥Àû À¯ÀüÀÚÀÇ ¹ßÇöÀº 60% ÀÌ»óÀÇ À¯ÀüÀÚ¿¡¼­ Áõ°¡ÇÏ¿´´Ù. µû¶ó¼­ MMTRÀÇ °áÇÕ´É º¯È­¿Í À¯ÀüÀÚ ¹ßÇö ¾ç»óÀÇ º¯È­ ¿ª½Ã 4°¡Áö À¯ÇüÀ» ³ªÅ¸³»¸ç, MMTRÀº À¯ÀüÀÚ¿¡ µû¶ó ¹ßÇö ¾ïÁ¦ ȤÀº °¨¼Ò¿¡ °ü¿©ÇÏ¿´´Ù. ºÐÈ­°úÁ¤ Áß MMTR °áÇÕÀÇ °¨¼Ò¿¡ µû¶ó ¹ßÇöÀÌ Áõ°¡ÇÏ´Â À¯ÀüÀÚµéÀº ¼¼Æ÷ ºÐÈ­/¹ß»ý¿¡ °ü·ÃµÈ À¯ÀüÀÚµéÀÌ ¸¹¾ÒÀ¸¸ç, ¹ßÇöÀÌ °¨¼ÒÇÏ´Â À¯ÀüÀÚµéÀº ¼¼Æ÷ ´ë»ç, ½ºÆ®·¹½º ¹ÝÀÀ µî¿¡ °ü·ÃµÈ À¯ÀüÀÚµéÀ̾ú´Ù. ÇÑÆí ºÐÈ­°úÁ¤ Áß MMTR °áÇÕ´ÉÀÌ Áõ°¡ÇÏ´Â À¯ÀüÀÚµéÀº ´ëºÎºÐ ¹ßÇöµµ Áõ°¡ÇÏ¿´À¸¸ç, À̵éÀº ¹ß»ý, Å»ÀλêÈ­ ¹× ¹è¾Æ ÇüÅÂÇü¼º¿¡ °ü·ÃµÈ °ÍµéÀ̾ú´Ù. ¶ÇÇÑ MMTR ¹ßÇö °¨¼â ȤÀº °ú¹ßÇö ¼¼Æ÷ÁÖ¸¦ ´ë»óÀ¸·Î d0 ¹× d3¿¡¼­ÀÇ 4°¡Áö ¹ßÇöº¯È­ À¯Çü¿¡ ¼ÓÇÏ´Â MMTR Ç¥ÀûÀ¯ÀüÀڵ鿡 ´ëÇÑ MMTR °áÇÕ´É º¯È­¸¦ ºñ±³ÇÑ °æ¿ì, ¸ðµç ±×·ì¿¡¼­ Ç¥ÀûÀ¯ÀüÀڵ鿡 ´ëÇÑ MMTR °áÇÕ´ÉÀº ´ëºÎºÐ °¨¼ÒÇÏ¿´À¸³ª, ¹ßÇö¾ç»óÀº °¨¼ÒÇÏ´Â À¯ÀüÀÚ¿Í Áõ°¡ÇÏ´Â À¯ÀüÀÚ¸¦ ¸ðµÎ Æ÷ÇÔÇϰí ÀÖ¾ú´Ù. µû¶ó¼­ MMTR °áÇÕ´É¿¡ µû¸¥ Ç¥Àû À¯ÀüÀÚÀÇ ¹ßÇö¾ç»óÀº À¯ÀüÀÚ¿¡ µû¶ó ´Ù¾çÇÏ°Ô Áõ°¡ ȤÀº °¨¼ÒÇÔÀ» ¾Ë ¼ö ÀÖ´Ù. MMTR ¹ßÇö°¨¼â ¹× °ú¹ßÇö ¼¼Æ÷ÁÖ¿¡¼­ÀÇ ¹ÌºÐÈ­¿Í ºÐÈ­°úÁ¤À» ÅëÇÕÇÏ¿© ºÐ·ùÇÑ 16°³ ±×·ìÀÇ À¯ÀüÀÚ ¹ßÇö º¯È­¾ç»óÀ» MMTR °áÇմɰú ºñ±³ÇÒ °æ¿ì, Ÿ ±×·ì¿¡ ºñÇØ ÀϺΠ±×·ì(±×·ì 5, 8, 9 ¹× 16)¿¡¼­ MMTR °áÇÕ´É °¨¼Ò¿¡ µû¸¥ ¹ßÇöÀÌ Áõ°¡ÇÏ´Â À¯ÀüÀÚ°¡ ¸¹±â´Â ÇÏÁö¸¸ Àü¹ÝÀûÀ¸·Î »ó±â¿Í À¯»çÇÑ ¾ç»óÀ» ³ªÅ¸³»¾ú´Ù. µû¶ó¼­, º» °á°ú´Â ¹ÌºÐÈ­ ¹× ºÐÈ­°úÁ¤ Áß¿¡ MMTRÀº ´Ù¾çÇÑ ´Ü¹éÁú º¹ÇÕü¸¦ Çü¼ºÇϸç, °¢ ´Ü¹éÁú º¹ÇÕü´Â Ç¥Àû¼­¿­°úÀÇ °áÇÕ À¯¹«¿¡ µû¶ó ´Ù¾çÇÏ°Ô Ç¥Àû À¯ÀüÀÚÀÇ ¹ßÇöÀ» ¾ïÁ¦ ȤÀº ÃËÁøÇÒ °ÍÀ̶ó´Â °¡Á¤À» µÞ¹ÞħÇÑ´Ù. ¸¶Áö¸·À¸·Î ¹è¾ÆÁٱ⼼Æ÷¿¡ Á¸ÀçÇÏ´Â MMTR °áÇմܹéÁúÀÇ µ¿Á¤°ú ÀÌ·¯ÇÑ °áÇմܹéÁú º¹ÇÕüÀÇ Á¸Àç ¿©ºÎ¸¦ °¢°¢ affinity purification-mass spectrometry ¹æ¹ý°ú gel filtration chromatography-western blot ¹æ¹ýÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. MMTR °áÇմܹéÁú·Î´Â Tip60-p400 º¹ÇÕüÀÇ ±¸¼º´Ü¹éÁúÀÎ Trrap, p400, Ruvbl1, Ruvbl2, actinÀº ¹°·Ð DNMT3A, Cullin A, WDRD9, MITF, NEK2 µîÀ» Æ÷ÇÔÇÏ¿© ¼ö½Ê Á¾¿¡ À̸£´Â ´Ü¹éÁúÀÌ µ¿Á¤µÇ¾ú´Ù. ¼ø¼ö Á¤Á¦ÇÑ MMTR º¹ÇÕü ´Ü¹éÁúÀÇ stoichiometry´Â Tip60-p400 º¹ÇÕü ±¸¼º´Ü¹éÁúÀÇ stoichiometry¿Í Â÷À̸¦ º¸ÀÌ´Â °ÍÀ¸·Î º¸¾Æ Tip60-p400 º¹ÇÕüÀÇ ÀϺΠ±¸¼º´Ü¹éÁúÀ» Æ÷ÇÔÇÏ´Â ´Ù¸¥ ´Ù¾çÇÑ º¹ÇÕü°¡ Á¸ÀçÇÒ °ÍÀ¸·Î Ã߷еǾú´Ù. ¶ÇÇÑ ¹è¾ÆÁٱ⼼Æ÷¿¡ Á¸ÀçÇÏ´Â MMTR º¹ÇÕü¸¦ gel filtration chromatography·Î ºÐ¼®ÇÑ °á°ú Àû¾îµµ 3°¡Áö MMTR º¹ÇÕü°¡ Á¸ÀçÇÔÀ» È®ÀÎÇÏ¿´´Ù. µû¶ó¼­ º¸´Ù Á¤±³ÇÑ ¹æ¹ý(MS-MS spectrometry ¹× co-IP)À¸·Î ºÐ¼®ÇÏ¿©¾ß ¹è¾ÆÁٱ⠼¼Æ÷ÁÖ¿¡ Á¸ÀçÇÏ´Â º¹ÇÕüÀÇ Á¾·ù¿Í ±¸¼º´Ü¹éÁúÀ» µ¿Á¤ÇÒ ¼ö ÀÖ°ÚÁö¸¸, º» °á°ú´Â ¹è¾ÆÁٱ⼼Æ÷¿¡´Â ´Ù¾çÇÑ Á¾·ùÀÇ MMTR º¹ÇÕü°¡ Á¸ÀçÇÔÀ» ½Ã»çÇÑ´Ù. °á·ÐÀûÀ¸·Î º» ¿¬±¸¿¡¼­´Â MMTR ¹ßÇöÀÌ ³ô°Å³ª ³·°Ô µÉ °æ¿ì Ç¥Àû À¯ÀüÀÚµéÀÇ ¹ßÇöÀÌ ºÒ±ÕÇüÇÏ°Ô µÇ¾î Ãʱ⠺ÐÈ­°¡ ÀϾÁö ¸øÇÏ°í ¼¼Æ÷»ç¸êÀÌ ÀϾÀ» ¹àÇû´Ù. ÀÌ·¯ÇÑ MMTRÀÇ ±â´ÉÀº MMTRÀÌ ´Ù¾çÇÑ ´Ü¹éÁú°ú º¹ÇÕü¸¦ Çü¼ºÇϸç, º¹ÇÕü º°·Î MMTR ÀÇÁ¸Àû ȤÀº ºñÀÇÁ¸ÀûÀ¸·Î Ç¥Àû À¯ÀüÀÚ ¹ßÇöÀ» ÃËÁø ȤÀº ¾ïÁ¦ÇÔÀ¸·Î½á ³ªÅ¸³¯ °ÍÀ¸·Î Ã߷еǾú´Ù. µû¶ó¼­, ¹è¾ÆÁٱ⼼Æ÷ÀÇ ¿î¸íÁ¶Àý¿¡ À־ MMTRÀº ºÐÀÚ °¡°¨ÀúÇ×±â(molecular rheostat)·Î ÀÛ¿ëÇÒ °ÍÀ̶ó Á¦¾ÈÇÑ´Ù.

[±¹³» ÇÐÀ§³í¹®]

½Ä¹°ÀÇ ¼¼Æ÷ºÐÈ­´Â ¿©·¯ Àü»çÀÎÀÚ¿Í ½ÅÈ£Àü´Þ À¯ÀüÀÚÀÇ ÀÛ¿ë¿¡ ÀÇÇØ¼­ Á¶ÀýµÈ´Ù. ½Ä¹°ÀÇ »Ñ¸® Ç¥ÇÇ ¼¼Æ÷´Â ÇÇÃþ ¼¼Æ÷¿ÍÀÇ »ó´ëÀû À§Ä¡¿¡ µû¶ó hair cell (H-cell)°ú non-hair cell (N cell)·Î ºÐÈ­ÇÑ´Ù. µÎ °³ÀÇ ÇÇÃþ ¼¼Æ÷ »çÀÌ ¿Ü°¢¿¡ À§Ä¡ÇÑ(H-position) Ç¥ÇÇ ¼¼Æ÷´Â H-cell·Î ºÐÈ­Çϰí, ±× ¿Ü ÇϳªÀÇ ÇÇÃþ ¼¼Æ÷ ¿Ü°û¿¡ À§Ä¡ÇÑ(N-position) Ç¥ÇÇ ¼¼Æ÷´Â N-cell·Î ºÐÈ­ÇÑ´Ù. R2R3 MYB Àü»çÀÎÀÚ¸¦ ¾ÏȣȭÇÏ´ÂWERWOLF´Â homeodomain leucine zipper (HD-ZIP)¸¦ ¾ÏȣȭÇÏ´Â GLABRA2 (GL2)ÀÇ ¹ßÇöÀ» ÃËÁøÇÏ¿© N-cell ºÐÈ­¸¦ À¯µµÇÑ´Ù. ¹Ý¸é¿¡ R3 MYB Àü»çÀÎÀÚ¸¦ ¾ÏȣȭÇÏ´ÂCAPRICE (CPC)¿Í TRIPTYCHON (TRY)´Â GL2ÀÇ ¹ßÇöÀ» ¾ïÁ¦ÇÏ¿© H-cell ºÐÈ­¸¦ À¯µµÇÑ´Ù. À̶§, WER¿Í CPC´Â basic helix-loop-helix (bHLH) Àü»çÀÎÀÚ¸¦ ¾ÏȣȭÇÏ´Â GLABRA3 (GL3)¿Í ENHANCER OF GLABRA3 (EGL3) ±×¸®°í WD40 ´Ü¹éÁúÀ» ¾ÏȣȭÇÏ´Â TRANSPARENT TESTA GLABRA1 (TTG1)°ú »óÈ£ÀÛ¿ëÇÏ¿© ÇÔ²² ±â´ÉÇÑ´Ù.
 wer-366 µ¹¿¬º¯ÀÌ´Â ³·Àº ¼öÁØÀÇ WER¸¦ ¹ßÇöÇϸ鼭µµ ¾ß»ýÇü°ú °ÅÀÇ ´ëµîÇÑ Ç¥ÇöÇüÀ» ³ªÅ¸³½´Ù. ÀÌ´Â ¾Ö±âÀå´ë À¯Àüü¿¡ WERÀÇ ±â´ÉÀ» º¸°­ÇÏ´Â À¯ÀüÀÚ°¡ Á¸ÀçÇÔÀ» ¾Ï½ÃÇÑ´Ù. ¿©·¯ À¯ÀüÀÚµé Áß GLABRA1 (GL1)Àº WER¿Í À¯»çÇÑ ºÐÀÚÀû ±âÀÛÀ» ÅëÇØ ÀÙÀÇ Ç¥ÇÇ ¼¼Æ÷¿¡¼­ trichome ¹ß´ÞÀ» Á¶ÀýÇÑ´Ù. ÀÙÀÇ Ç¥ÇÇ ¼¼Æ÷¿¡¼­´Â R2R3 MYB Àü»çÀÎÀÚ¸¦ ¾ÏȣȭÇÏ´Â GL1ÀÌ GL2ÀÇ ¹ßÇöÀ» ÃËÁøÇÏ¿© ¸ð¿ë ¼¼Æ÷ ºÐÈ­¸¦ À¯µµÇÏÁö¸¸ CPC´Â GL2ÀÇ ¹ßÇöÀ» ¾ïÁ¦ÇÏ¿© ºÐÈ­¸¦ ¸·´Â´Ù. ¶ÇÇÑ, GL1°ú WER´Â º¸Á¸µÈ R2R3 µµ¸ÞÀΰú Àü»çȰ¼º µµ¸ÞÀÎÀ» °øÀ¯Çϸç, ¼­·ÎÀÇ ±â´ÉÀ» ´ëüÇÒ ¼ö ÀÖ´Ù°í º¸°íµÇ¾ú´Ù. º» ¿¬±¸¿¡¼­´Â ÀÌ·¯ÇÑ ¹è°æÀ» ±Ù°Å·Î, »Ñ¸® Ç¥ÇÇ ¼¼Æ÷ÀÇ ¿î¸í °áÁ¤¿¡ °ü¿©ÇÏ´Â GL1ÀÇ ¿ªÇÒÀ» ±Ô¸íÇÏ¿´´Ù.
 gl1 µ¹¿¬º¯À̵é°ú 35Sp:GL1¶Ç´Â Q2610>>GL1°ú °°Àº GL1ÀÇ °ú´ë¹ßÇö ½Ä¹°¿¡¼­´Â ³»»ýÀûÀÎ WERÀÇ °­ÇÑ ¹ßÇö ¶§¹®¿¡ ¾ß»ýÇü°ú ´ëµîÇÑ Ç¥ÇöÇüÀ» ³ªÅ¸³»¾ú´Ù. µû¶ó¼­, WER°¡ ³·Àº ¼öÁØÀ¸·Î ¹ßÇöÇÏ´Â wer-366 ¹Î°¨¼º ¹è°æÀ» Ȱ¿ëÇÏ¿© GL1ÀÇ »Ñ¸® Ç¥ÇÇ ¼¼Æ÷ÀÇ ¿î¸í °áÁ¤¿¡ ´ëÇÑ ¿ªÇÒÀ» Á¶»çÇÑ °á°ú, wer-366¿¡ ºñÇØ¼­ wer-366 gl1 ÀÌÁß µ¹¿¬º¯ÀÌ´Â N-position¿¡¼­ N-cellÀÇ ºñÀ²ÀÌ °¨¼ÒÇϴ ǥÇöÇüÀ» ³ªÅ¸³Â´Ù. N-cellÀÌ ÀϺΠÁõ°¡ÇÏ´Â ´Ù¸¥ À¯ÇüÀÇ ¹Î°¨¼º ¹è°æÀÎ cpc¿¡¼­ GL1ÀÇ ±â´ÉÀ» Ãß°¡·Î °ËÁõÇÑ °á°ú, cpc¿¡ ºñÇØ¼­ cpc gl1 ÀÌÁß µ¹¿¬º¯ÀÌ´Â H-position¿¡¼­ N-cellÀÇ ºñÀ²ÀÌ °¨¼ÒÇϴ ǥÇöÇüÀ» ³ªÅ¸³Â´Ù. µû¶ó¼­ GL1ÀÇ ±â´ÉÀº N-cellÀÇ Æ¯¼ºÈ­¸¦ À¯µµÇÏ´Â °ÍÀ¸·Î »ç·áµÈ´Ù.
 GL1 ÇÁ·Î¸ðÅÍ¿¡ ÀÇÇØ ¹ßÇöµÇ´Â ¸®Æ÷ÅÍ À¯ÀüÀÚµéÀ» ÅëÇØ »Ñ¸®¿¡¼­ GL1ÀÇ ¹ßÇö ¾ç»óÀ» °üÂûÇÑ °á°ú, GL1ÀÇ ¹ßÇöÀº ÁÖ·Î N-position¿¡¼­ ³ªÅ¸³µ´Ù. ¶ÇÇÑ, ±âÁ¸¿¡ ¾Ë·ÁÁø »Ñ¸® Ç¥ÇÇ ¼¼Æ÷ÀÇ ¿î¸íÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚµé°ú GL1ÀÇ À¯ÀüÇÐÀû »ó°ü °ü°è¸¦ °ËÁõÇϱâ À§ÇØ, ±³¹è¸¦ ÅëÇØ GL1 ÇÁ·Î¸ðÅÍ¿¡ ÀÇÇØ ±¸µ¿µÇ´Â ¸®Æ÷ÅÍ À¯ÀüÀÚµéÀ» ÇØ´ç µ¹¿¬º¯ÀÌ ¶Ç´Â °ú´ë¹ßÇö ¶óÀÎ ¹è°æ¿¡ µµÀÔÇÏ¿´´Ù. ±× °á°ú, GL1ÀÇ ¹ßÇöÀº WER, GL3, EGL3 ±×¸®°í TTG1¿¡ ÀÇÇØ¼­ ¾ç¼ºÀûÀ¸·Î Á¶ÀýµÇ¸ç, CPC, TRY ±×¸®°í GL2¿¡ ÀÇÇØ¼­ À½¼ºÀûÀ¸·Î Á¶ÀýµÇ´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù. ¶ÇÇÑ GL1 ÇÁ·Î¸ðÅÍ¿¡ ÀÇÇØ ±¸µ¿µÇ´Â GFP-GL1 À¶ÇÕ ´Ü¹éÁúÀÇ ¹ßÇöÀº ¾ß»ýÇü ¹è°æ¿¡¼­ ÁÖ·Î N-cellÀÇ ÇÙ ³»¿¡¼­ °üÂûµÇ¾ú´Ù. ÀÌ´Â GL1ÀÌ ºñÀ̵¿¼º ´Ü¹éÁúÀ̶ó´Â °ÍÀ» Á¦½ÃÇÑ´Ù.
 À§ °á°úµéÀ» Á¾ÇÕÇϸé, »Ñ¸® Ç¥ÇÇ ¼¼Æ÷ÀÇ ¿î¸í °áÁ¤ °úÁ¤¿¡¼­ GL1Àº WERÀÇ ÇÏ·ù¿¡¼­ N-cellÀÇ Æ¯¼ºÈ­¸¦ ºÎºÐÀûÀ¸·Î º¸°­Çϸç CPC, TRY ¿Í GL2¿¡ ÀÇÇØ¼­ À½¼ºÀûÀ¸·Î Á¶ÀýµÇ´Â °ÍÀ¸·Î »ç·áµÈ´Ù.

[±¹³» ÇÐÀ§³í¹®]

ÇǺΠ»óÇÇ¿Í ÁøÇÇ, ±×¸®°í ¸ð³¶ÀÇ ¹ß´Þ°ú À¯Áö´Â ÇǺÎÀÇ À庮 ±â´É¿¡ Áß¿äÇÏ´Ù. ÇǺΠ³» ¼¼Æ÷µéÀº ¿ÜºÎ ȯ°æ¿¡ Áö¼ÓÀûÀ¸·Î ³ëÃ⠵Ǹç, Áõ½Ä°ú »ç¸êÀ» ¹Ýº¹Çϱ⠶§¹®¿¡ ÇǺÎÀÇ Ç×»ó¼º Á¶ÀýÀ» À§ÇÑ Á¤¹ÐÇÑ À¯ÀüÀÚ ¹ßÇö Á¶ÀýÀÌ ÇÊ¿äÇÏ´Ù. ÈļºÀ¯ÀüÇÐÀû Á¶Àý ÀÎÀÚ Áß H3K27m3, H3K4me3 ¹× H3K9me3¿Í °°Àº ÁÖ¿äÇÑ È÷½ºÅæ º¯ÇüÀÇ ±âÀú »óŰ¡ ÇǺΠ¼¼Æ÷µé¿¡¼­ ¿¬±¸µÇ¾úÀ½¿¡µµ ºÒ±¸Çϰí, À̵éÀÇ Á¶Àý ±âÀü¿¡ ´ëÇÑ ¿¬±¸´Â ¹ÌÈíÇÏ´Ù. ASXL1 À¯ÀüÀÚ´Â ÈļºÀ¯ÀüÇÐÀû ÀÌÁß Á¶Àý ÀÎÀڷμ­, Polycomb repressive complex 2¿Í °áÇÕÇÏ¿© H3K27me3¸¦, Trithorax º¹ÇÕü¿Í °áÇÕÇÏ¿© H3K4me3¸¦ Á¶ÀýÇϱ⠶§¹®¿¡, ASXL1 À¯ÀüÀÚ°¡ ÇǺΠ¼¼Æ÷³» ÈļºÀ¯ÀüÇÐÀû Á¶Àý ±âÀüÀ» ÀÌÇØÇϴµ¥ ´Ü¼­°¡ µÉ °ÍÀ̶ó »ç·áµÇ¾ú´Ù. ÇǺΠ¼¼Æ÷ Áß »óÇÇÀÇ °¢Áú¼¼Æ÷¿Í ÁøÇÇÀÇ ¼¶À¯¾Æ¼¼Æ÷´Â ³¶¹è Çü¼º ½Ã »ï¹è¿±À¸·ÎºÎÅÍ ±â¿øÀÌ ´Ù¸£±â ¶§¹®¿¡, °¢Áú¼¼Æ÷¿Í ¼¶À¯¾Æ¼¼Æ÷ÀÇ À¯ÀüÀÚ ¹ßÇöÀº ±¸ºÐ µÇ¾î¾ß ÇÑ´Ù. µû¶ó¼­ º» ¿¬±¸¿¡¼­´Â KO ¸¶¿ì½º ¸ðµ¨À» Ȱ¿ëÇÑ Asxl1 À¯ÀüÀÚÀÇ ¿ªÇÒÀ» »óÇÇ¿Í ÁøÇÇ, µÎ ´Ü¿øÀ¸·Î ³ª´©¾î ±â¼úÇϰíÀÚ ÇÑ´Ù. ¸ÕÀú, Asxl1 KO »ýÁãÀÇ ÅÂ¾Æ ÇǺΠ¹ß»ý °úÁ¤¿¡¼­ »óÇÇÀÇ ºÐÈ­¿Í ÃþÈ­ Çö»ó¿¡ ¹ß´Þ °áÇÔÀÌ °üÂû µÇ¾ú´Ù. Àü»çü ºÐ¼®¿¡¼­´Â Asxl1 KO¿¡ ÀÇÇÏ¿© ¹ßÇöÀÌ º¯È­µÈ À¯ÀüÀÚµéÀÌ »óÇÇ ¹ß´Þ, ¸ð³¶, ±×¸®°í ¿©·¯ È÷½ºÅæ º¯ÇüµéÀÇ Ç¥Àû À¯ÀüÀÚÀÓÀÌ ¹àÇôÁ³´Ù. ÀÌ¿¡ À̾î, ÅÂ¾Æ °¢Áú¼¼Æ÷¸¦ ºÐ¸® °üÂûÇÑ °á°ú, ½É°¢ÇÑ ¼¼Æ÷ ¼ºÀåÀÇ °áÇÔ°ú ¼¼Æ÷ ³ëÈ­ Çö»óÀÌ °üÂû µÇ¾ú´Ù. ºÒ¸êÈ­µÈ Àΰ£ °¢Áú¼¼Æ÷ÁÖÀÎ HaCaT¿¡¼­ ASXL1 À¯ÀüÀÚ¸¦ KDÇÑ °á°ú Ä®½·¿¡ ÀÇÇÑ ºÐÈ­¿Í ±¸Ã¼ Çü¼º½Ã ³ªÅ¸³ª´Â ÃþÈ­ Çö»ó¿¡ °áÇÔÀÌ ¹ß»ýÇÏ¿´´Ù. RNA-seqÀÇ ±â´ÉÀû ºÐ¼® °á°ú¿¡¼­ Asxl1°ú ¿¬°ü µÉ °¡´É¼ºÀÌ ÀÖ´Â ¿©·¯ Àü»ç ÀÎÀÚ¸¦ Ž»öÇÏ¿© Àü»ç ÀÎÀÚ Tp63À» ¹ß±¼ÇÏ¿´´Ù. KO »ýÁã¿Í ¼¼Æ÷ ¼öÁØÀÇ ±â´É »ó½Ç ¿¬±¸¿¡¼­ °üÂûµÈ Tp63 À̳ª Asxl1¿¡ ÀÇÇÑ Ç¥ÇöÇüÀÌ ºñ½ÁÇÏ¿´´Ù. ¶ÇÇÑ, Tp63 °á¼ÕÀÌ ¾ß±âÇÏ´Â H3K27me3 ¹× H3K9me3ÀÇ ¿°»öü ³» ºÐÆ÷ ÀÌ»ó Çö»ó ¶ÇÇÑ Asxl1 À¯ÀüÀÚ¿ÍÀÇ ¿¬°ü °¡´É¼ºÀ» Á¦½ÃÇÏ¿´´Ù. ¸é¿ªÄ§°­ ½ÇÇè °á°ú ASXL1Àº TAp63¥á ¹× DNp63¥á¿Í ¹°¸®ÀûÀ¸·Î °áÇÕÇÑ´Ù´Â »ç½ÇÀ» °üÂûÇÏ¿´´Ù. Tp63ÀÇ ChIP DB¿¡ ±Ù°ÅÇÏ¿© motif ºÐ¼® ÈÄ, ChIP ½ÇÇèÀ» ÅëÇÏ¿© Asxl1-Tp63ÀÌ ¿°»öü¿¡ ÇÔ²² °áÇÕÇÏ¿© ÀÖÀ½À» °üÂûÇÏ¿´´Ù. ÀÌ¿¡ À̾î, ASXL1 KD HaCaT ¼¼Æ÷¿¡¼­ Ä®½· ó¸® ½Ã »óÇÇ ¹ß´Þ¿¡ ÁÖ¿äÇÑ ´Ù¼öÀÇ À¯ÀüÀڵ鿡¼­ È÷½ºÅæ ¾ïÁ¦ÄÚµå H3K27me3¿Í H3K9me3°¡ È÷½ºÅæ Ȱ¼º ÄÚµå H3K4me3 º¸´Ù »ó´ëÀûÀ¸·Î ¸¹ÀÌ Á¸ÀçÇÔÀ» °üÂûÇÏ¿©, ASXL1ÀÌ Tp63°ú °áÇÕÇÏ¿© »óÇÇ ¹ß´Þ À¯ÀüÀÚÀÇ ¹ßÇö¿¡ Áß¿äÇÑ
 ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î º¸¿©Áø´Ù. ´ÙÀ½À¸·Î, Asxl1°ú Tp63ÀÇ KO ÅÂ¾Æ ÇǺΠRNA-seq ºñ±³ ºÐ¼®¿¡¼­ Áö¹æ ¼¼Æ÷ ºÐÈ­¿Í ±ÙÀ° ¼¼Æ÷ ºÐÈ­ °ü·Ã À¯ÀüÀÚÀÇ ¹ßÇö Áõ°¡°¡ °üÂûµÇ¾î ÁøÇÇ ¼¶À¯¾Æ¼¼Æ÷¿¡¼­ Asxl1°ú Tp63ÀÌ ¼¼Æ÷ À¯Áö¿¡ ÇÊ¿äÇÑ °ÍÀ¸·Î »ç·á µÇ¾ú´Ù. ÅÂ¾Æ ÇǺο¡¼­ ºÐ¸®µÈ Asxl1 KO ¼¶À¯¾Æ¼¼Æ÷¿¡¼­ ¼¼Æ÷ ³ëÈ­¿¡ ±âÀÎÇÑ ¼¼Æ÷ Áõ½Ä °¨¼Ò Çö»óÀÌ °üÂû µÇ¾ú´Ù. ÀÌ ¶§, Asxl1 KO ¼¶À¯¾Æ¼¼Æ÷´Â ¿¹±âÄ¡ ¸øÇÑ Áö¹æ ¼¼Æ÷ ºÐÈ­ Ç¥ÇöÇüÀ» º¸¿´´Ù. Áö¹æ ¼¼Æ÷ ºÐÈ­¸¦ ÃËÁø ½ÃŰ´Â ¹è¾ç¾× ¿¡¼­µµ Asxl1 KO ¼¶À¯¾Æ¼¼Æ÷°¡ ´ëÁ¶±º¿¡ ºñÇØ ´õ ºü¸£°í ºó¹øÇÏ°Ô Áö¹æ ¼¼Æ÷·Î ºÐÈ­ÇÏ¿´´Ù. Asxl1Àº ±âÁ¸¿¡ 3T3-L1 ¼¼Æ÷¿¡¼­ Áö¹æ ¼¼Æ÷ ºÐÈ­ ¾ïÁ¦ À¯ÀüÀÚ·Î ¾Ë·ÁÁ³À¸³ª, Tp63Àº Áö¹æ ¼¼Æ÷¿Í °ü·ÃµÈ ±â´ÉÀÇ °üÂûÀÌ ¹ÌÈíÇÏ´Ù. ³ëÈ­ °ü·Ã ¼¼Æ÷ÀÇ ´ë»ç´Â Áö¹æ ¼¼Æ÷ÀÇ Æ¯Â¡À» ÃËÁø½Ã۱⠶§¹®¿¡ ³ëÈ­¿¡ ÀÇÇÑ Áö¹æ ¼¼Æ÷ ºÐÈ­¿¡¼­ Asxl1-Tp63¿¡ ÀÇÇÑ ºÐÀÚ»ý¹°ÇÐÀû ±âÀüÀ» ÀÌÇØÇÏ´Â °ÍÀº ¼¶À¯¾Æ¼¼Æ÷ÀÇ À¯Áö¿¡ ´ëÇÑ »õ·Î¿î ÅëÂûÀ» Á¦°øÇÒ
 °ÍÀÌ´Ù. º» ¿¬±¸ÀÇ °á°úµéÀ» Á¾ÇÕÀûÀ¸·Î ±â¼úÇÏÀÚ¸é, ASXL1 À¯ÀüÀÚ´Â ÇǺΠ¹ß´Þ °úÁ¤ Áß °¢Áú¼¼Æ÷¿Í ¼¶À¯¾Æ¼¼Æ÷ÀÇ À¯ÀüÀÚ ¹ßÇö Á¶ÀýÀ» ÅëÇÏ¿© ¼¼Æ÷ ¿î¸íÀ» °áÁ¤ÇÏ´Â ÇÙ½ÉÀûÀÎ ÀÎÀÚÀÌ´Ù. ASXL1Àº »óÇÇÀÇ °¢Áú¼¼Æ÷¿¡¼­´Â ºÐÈ­¸¦ ÃËÁøÇÔ°ú µ¿½Ã¿¡ ÁøÇÇÀÇ ¼¶À¯¾Æ¼¼Æ÷¿¡¼­´Â ³ëÈ­ ¹× ¿¹±âÄ¡ ¸øÇÑ ºÐÈ­¸¦ ¾ïÁ¦ÇÏ´Â ¿ªÇÒÀ» ¼öÇàÇÑ´Ù. ÀÌ¿Í °ü·ÃÇÏ¿©, ÇǺΠ¼¼Æ÷µé¿¡¼­ ASXL1-Tp63°ú ¿¬°üµÈ ÈļºÀ¯ÀüÇÐÀû º¯ÇüÀÎÀڵ鿡 ´ëÇÑ Ãß°¡ÀûÀÎ ¿¬±¸´Â ÇǺÎÀÇ À¯Áö¿Í ºÐÈ­¿¡ °ü·ÃµÈ Àü»ç Á¶Àý¿¡ ´ëÇÑ ¿ì¸®ÀÇ ÀνÄÀ» ³ÐÇô ÁÙ °ÍÀ¸·Î ¿¹»óµÈ´Ù. Çٽɾî: Asxl1, p63, ÈļºÀ¯ÀüÇÐ, ÇǺΠ¹ß´Þ, °¢Áú ¼¼Æ÷, ¼¶À¯¾Æ¼¼Æ÷

[ÇØ¿Ü³í¹®]

Fate of lentinan, which is one of antitumor polysaccharides, was investigated with 3H-lentinan. 3H-lentinan was prepared by Wilzbach 3H gas exposure labeling, then purified by the gel filtration chromatography. 1) After a single intravenous injection of 3H-lentinan, radioactivity in plasma declined in a biphasic process. 2) There were urinary and fecal excretion, but expiratory excretion was a small proportion. 3) The radioactivity was predominantly incorporated into the liver and spleen, indicating selective retention of the lentinan in reticuloendothelial system cells. On the other hand the level of radioactivity in the lung and kidneys was dropped rapidly. 4) We can not find the selective incorporation of radioactivity into the tumor. 5) There was no species difference on the distribution of lentinan among mouse, rat and dog. 6) These results obtained were similar to other polysaccharides and immunologic antitumor agents.

[±¹³» ÇÐÀ§³í¹®]

MMTR(Mat1-Mediated Transcriptional Repressor)Àº ¸ðµç ÁøÇÙ¼¼Æ÷¿¡ Á¸ÀçÇÏ´Â À¯ÀüÀڷμ­ DNMT1 °áÇÕ ´Ü¹éÁú(DNMT1-associated protein 1/Dmap1)·Î óÀ½ µ¿Á¤µÇ¾ú´Ù. ¶ÇÇÑ MMTR/Dmap1Àº ÀüºÐÈ­´É Áٱ⼼Æ÷ÀÇ ¿î¸í °áÁ¤À» Á¶ÀýÇÏ´Â Myc ¸ðµâ°ú Å©·Î¸¶Æ¾ ¸®¸ðµ¨¸µ º¹ÇÕüÀÎ Tip60-p400 º¹ÇÕüÀÇ ±¸¼º¿øÀÌ´Ù. º» ¿¬±¸¿¡¼­´Â »ý¹°Á¤º¸ÇÐÀû ¹æ¹ýÀ» ÅëÇØ ÀüºÐÈ­´É Áٱ⼼Æ÷ÀÇ ¿î¸í Á¶Àý¿¡ À־ MMTR/Dmap1ÀÇ ÀÛ¿ë ±âÀÛÀ» ÀÌÇØÇϰíÀÚ ÇÏ¿´´Ù. ¿ì¼±, »ýÁã ¹è¾ÆÁٱ⼼Æ÷¿¡¼­ Áٱ⼼Æ÷´É À¯Áö¿¡ Áß¿äÇÑ ÃÑ 38Á¾ÀÇ Àü»çÀÎÀÚ, È÷½ºÅæ ¼ö½ÄÈ­, Å©·Î¸¶Æ¾ ¸®¸ðµ¨¸µ º¹ÇÕü ±¸¼º´Ü¹éÁúÀ» ´ë»óÀ¸·Î Àü»ç °³½ÃÁ¡ »ó/ÇÏÀ§ 1 kb À̳»¿¡ °áÇÕÇϰí Àִ ǥÀû¿°±â¼­¿­¿¡ ´ëÇÑ ChIP-sequencing ¹× ChIP-chip µ¥ÀÌÅ͸¦ ¼öÁýÇÑ ÈÄ HeatmapÀ» ÅëÇÏ¿© MMTR/Dmap1ÀÌ °áÇÕÇϴ ǥÀû¼­¿­°ú ºñ±³ÇÏ¿© °øÅë Ç¥Àû À¯ÀüÀÚ ¿©ºÎ¸¦ È®ÀÎÇÏ¿´À¸¸ç, °øÅë Ç¥Àû¼­¿­À» Áö´Ï°í ÀÖ´Â À¯ÀüÀÚÀÇ ±â´ÉÀ» Gene ontology µµ±¸¸¦ »ç¿ëÇÏ¿© ºÐ¼®ÇÏ¿´´Ù. MMTR/Dmap1ÀÇ Ç¥ÀûÀ¯ÀüÀÚ´Â ÁÖ·Î amino acid activation, mitosis, RNA localization ¹× RNA splicing¿¡ °ü¿©ÇÏ´Â °æÇâÀÌ ³ô¾ÒÀ¸¸ç Áٱ⼼Æ÷´É À¯Áö ¹× ºÐÈ­Á¶Àý °ü·Ã Ç¥ÀûÀ¯ÀüÀÚ´Â °ÅÀÇ Á¸ÀçÇÏÁö ¾Ê¾Ò´Ù. MMTR/Dmap1Àº Àü»çÀÎÀÚ c-Myc, n-Myc, Max, E2f1, E2f4, Zfx¿Í °áÇÕºÎÀ§¸¦ °øÀ¯ÇÏ´Â °æÇâÀÌ °­ÇÏ¿´À¸¸ç, Tip60-p400 Å©·Î¸¶Æ¾ º¹ÇÕüÀÇ ±¸¼º´Ü¹éÁúÀÎ Tip60¿Í´Â Á¦ÇÑÀûÀ¸·Î Ç¥ÀûÀ¯ÀüÀÚ¸¦ °øÀ¯Çϰí ÀÖ¾ú´Ù. ÀÌ·¯ÇÑ °øÅë °áÇÕºÎÀ§ÀÇ È÷½ºÅæÀº ¾Æ¼¼Æ¿È­ (AcH3, AcH4) µÇ¾î ÀÖ°í, ÀϽÃÀûÀÎ Àü»ç ¸ØÃã¿¡ °ü¿©ÇÏ´Â H3K27me3 ¹× ¸ÞƿȭµÈ CytosineÀ» 5-hydroxymethyl C·Î º¯È¯½ÃŰ´Â Tet1µµ °øÅëÀûÀ¸·Î °áÇÕÇϰí ÀÖ¾ú´Ù. ¸¶Áö¸·À¸·Î ¹ÌºÐÈ­ ¹× ºÐÈ­ 3ÀϰÀÇ »ýÁã ¹è¾ÆÁٱ⼼Æ÷¿¡¼­ÀÇ °øÅë Ç¥ÀûÀ¯ÀüÀÚ ¹ßÇö¾ç»ó º¯È­¸¦ ºÐ¼®ÇÑ °á°ú, À̵éÀº ºÐÈ­¿¡ µû¶ó ´Ù¾çÇÑ ¹ßÇöÀÇ º¯È­¸¦ ³ªÅ¸³»¾ú´Ù. ¶ÇÇÑ MMTR/Dmap1 Àüü ȤÀº MMTR/Dmap1ÀÇ N-¸»´Ü ¹ÝÂÊÀ» °ú¹ßÇö ½ÃŲ ¼¼Æ÷¿¡¼­ÀÇ Ç¥ÀûÀ¯ÀüÀÚ ¹ßÇö¾ç»óÀº MMTR/Dmap1À» knockdown ½ÃŲ ¼¼Æ÷¿¡¼­ÀÇ ¹ßÇö¾ç»ó°ú À¯»çÇÑ ¹Ý¸é MMTR/Dmap1ÀÇ C-¸»´Ü ¹ÝÂÊÀ» °ú¹ßÇö ½ÃÄ×À» ¶§ÀÇ ¹ßÇö¾ç»ó°ú´Â Â÷À̸¦ ³ªÅ¸³»¾ú´Ù. µû¶ó¼­ »ýÁã ¹è¾ÆÁٱ⼼Æ÷¿¡¼­ MMTR/Dmap1Àº Myc ±×·ìÀÇ Àü»çÀÎÀÚµé°ú ÇÔ²² Áٱ⼼Æ÷´É À¯Áö³ª ºÐÈ­Á¶Àýº¸´Ù´Â ´Ù¾çÇÑ ±âÃÊ ¹°Áú´ë»ç °ü·Ã À¯ÀüÀÚµéÀÇ ¹ßÇöÀ» µ¿ÀûÀ¸·Î Á¶ÀýÇÏ´Â ±â´É¿¡ °ü¿©Çϸç, ÀÌ·¯ÇÑ ±â´ÉÀÇ ÀϺδ Tip60-p400 Å©·Î¸¶Æ¾ ¸®¸ðµ¨¸µ º¹ÇÕüÀÇ ±¸¼º¿øÀ¸·Î ÀÛ¿ëÇÏ¿© ³ªÅ¸³»´Â ¹Ý¸é ÀϺδ MMTR/Dmpa1 ´Üµ¶ ȤÀº ´Ù¸¥ ´Ü¹éÁú°úÀÇ »óÈ£ÀÛ¿ëÀ» ÅëÇÏ¿© ÀÌ·ç¾îÁú °ÍÀ¸·Î ÃßÁ¤µÈ´Ù.

[±¹³» ÇÐÀ§³í¹®]

º» ³í¹®Àº ÁÖ¼¼Æä º£¸£µð(Giuseppe Fortunino Francesco Verdi, 1813-1901)ÀÇ Áß±âÀÛǰ Áß ÇϳªÀÎ ¿ÀÆä¶ó ¡¶¿î¸íÀÇ Èû¡·(La Forza del Destino)ÀÇ Àü¸· °ø¿¬¿¡ ¿ÀÆä¶ó ÇǾƴϽºÆ®·Î½á Âü¿©ÇÏ¸ç ½ÃÀÛµÈ ¿¬±¸ÀÇ °á°ú¹°ÀÌ´Ù.1) °ø¿¬ Á¦ÀÛ¿¡ Âü¿©Çϸ鼭 ÀÌ ÀÛǰÀÇ Á߿䵵¿¡ ºñÇÏ¿© ³í¹®À» ºñ·ÔÇÑ Àü¹®¼­Àû µî ±¹³»¿¡¼­ Âü°íÇÒ ¼ö ÀÖ´Â Çмú¼­°¡ ºÎÁ·ÇÔÀ» ¾Ë°Ô µÇ ¾ú°í ÀÌ ÀÛǰÀÇ À½¾Ç°ú ¹®ÇÐÀû °¡Ä¡, ±×¸®°í ûÁßÀ» »ç·ÎÀâ´Â ¸Å·ÂÀ» ´À ²¸ ¿¬±¸¿¡ ÀÓÇÏ°Ô µÇ¾ú´Ù. º» ¿¬±¸¿¡¼­ ¿ÀÆä¶ó ¡¶¿î¸íÀÇ Èû¡·ÀÌ ÀÛ°îµÈ Èı⠳¶¸¸ ¿ÀÆä¶óÀÇ Æ¯Â¡ °ú ÀÛǰ ¾È¿¡¼­ µå·¯³­ ÀÛ°î °æÇâÀ» ¿¬±¸ÇÏ¿´´Ù. ƯÈ÷ ÁýÁßÇÏ¿© ¿¬±¸ÇÑ °ÍÀº ÀÌ ÀÛǰ¿¡¼­ ºñ±ØÀÌ ÁßøµÇ¾î Àü°³µÇ´Â À̾߱â¿Í ºÒÇàÇÏ°í ¹«°Å¿î ij¸¯Å͸¦ °¡Áö´Â ÁÖÀΰøµé°ú È®¿¬È÷ ºñ±³µÇ´Â ÇÑ Àι°, ¼öµµ»ç¡®¸á¸®Åä ³×¡¯(Fra Melitone)ÀÇ È°¾àÀÌ µ¸º¸ÀÌ´Â 4¸· 1ÀåÀÌ´Ù. ±×¸®°í ¸á¸®Åä³×°¡ ÀÛǰ¿¡¼­ °¡Áö´Â ÀǹÌ, ÀǵµÀûÀ¸·Î ¸ð¼øÀûÀÎ Ãø¸éÀ» ³»Æ÷ÇÑ Ä³¸¯Å͸¦ À½ ¾ÇÀû Ư¡°ú È­¼ºÀÇ ÁøÇàÀ¸·Î ºÐ¼®ÇϰíÀÚ ÇÏ¿´´Ù. ´õ ³ª¾Æ°¡ 4¸· 1ÀåÀÇ ÅØ½ºÆ®¿Í ÇÔ²² ¿ÀÄɽºÆ®¶ó, ÇÕâ, µ¶Ã¢ÀÚÀÇ À½¾ÇÀû ¹èÄ¡¸¦ ºÐ¼®ÇÏ¿´°í, ¿À ÄɽºÆ®¶ó ÃѺ¸¸¦ ¹ÙÅÁÀ¸·Î ¾Ç±â ±¸¼ºÀ» ºÐ¼®ÇÔÀ¸·Î ¿ÀÄɽºÆ®¶óÀÇ »öä¿Í À½ÇâÀ» ÇÇ¾Æ³ë ¹ÝÁÖ¿¡ È¿°úÀûÀ¸·Î ¹Ý¿µÇÒ ¼ö ÀÖµµ·Ï ¿¬±¸ÇÏ¿´´Ù. º» ¿¬±¸¸¦ ÅëÇØ ¿ÀÆä¶ó ¿î¸íÀÇ Èû¿¡ °üÇÑ Çй®Àû ºÐ¼®»Ó¸¸ÀÌ ¾Æ´Ï¶ó ½Ç Á¦ Á¦ÀÛÇÏ´Â °úÁ¤¿¡¼­ ¾ò¾ú´ø °æÇèÀû Áö½ÄÀÌ ÀÌ ÀÛǰÀ» ¿¬±¸ÇÏ´Â »ç¶÷µé °ú ƯÈ÷ ¿ÀÆä¶ó ¹ÝÁÖ¸¦ ÇÏ´Â À̵鿡°Ô µµ¿òÀÌ µÇ°íÀÚ ÇÑ´Ù. 1) 2023³â 11¿ù 8-11ÀϱîÁö ´ëÀü¿¹¼úÀÇÀü´ç ¾ÆÆ®È¦¿¡¼­ °ø¿¬ ¿¹Á¤À̾ú´ø ´ëÀü¿¹¼úÀÇÀü´ç °³°ü 30ÁÖ ³â ±â³ä ¿ÀÆä¶ó ¡®¿î¸íÀÇ Èû¡¯ÀÇ ÇǾƴϽºÆ®·Î Âü¿©ÇÏ¿´´Ù. ÇÏÁö¸¸ ¹«´ë ¼¼Æ® ¹Ì¿Ï¼ºÀ¸·Î ÀÎÇØ °èȹµÈ ³¯Â¥¿¡ °ø¿¬ÀÌ ÀÌ·ç¾îÁöÁö ¾Ê¾Ò°í, ³¯Â¥°¡ ¹Ù²î¾î °ø¿¬µÉ ¿¹Á¤ÀÌ´Ù.

[±¹³»³í¹®]

¹Ý¿ù»ó ¿¬°ñ ºÀÇÕ¼ú ½Ã ¿©·¯ Á¾·ùÀÇ Èí¼ö¼º ¶Ç´Â ºñÈí¼ö¼º ºÀÇÕ»çµéÀÌ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ¼úÀÚ¿¡ µû¶ó ºñÈí¼ö¼º ºÀÇջ簡 Èí¼ö¼º ºÀÇջ翡 ºñÇØ ¾ÈÁ¤µÈ °íÁ¤·ÂÀ» Á¦°øÇÑ´Ù°í ÇÏ¿© ºñÈí¼ö¼º ºÀÇջ縦 ¼±È£Çϱ⵵ ÇÑ´Ù. ±×·¯³ª ºÀÇջ簡 ºÀÇÕºÎÀ§¿¡ Áö¼ÓÀûÀ¸·Î ³²¾ÆÀÖÀ» °æ¿ì ÀÌ·Î ÀÎÇÑ ¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç, ÀúÀÚµéÀº Inside-Out ¹Ý¿ù»ó ¿¬°ñ ºÀÇÕ¼ú¿¡¼­ ºñÈí¼ö¼º ºÀÇջ簡 ¹Ý¿ù»ó ¿¬°ñ ½ÇÁúºÎ¸¦ °üÅëÇÏ¿© Èij»Ãø °üÀý¸· ¹ÛÀ¸·Î ¹Ð·Á³ª¿Â Áõ·Ê¸¦ °æÇèÇÏ¿´±â¿¡ À̸¦ º¸°íÇϰíÀÚ ÇÑ´Ù.

[±¹³»³í¹®]

The March 1st Movement in Korea and the May 4th Movement in China are both resistance movements against Japanese aggression policy. In 1910s, Korea became a Japanese colony under the rule of Gendarmerie, while China, accepting the twenty-one demands of Japan, was on the verge of subjugation. When the World War I ended and the Paris Peace conference began, both the Koreans and Chinese had great hopes on this conference. They were eager to solve the Korean independence problem and China's Shandong problem through the principle of ¡°National Self-determination¡± put forward by US President Wilson. However, the interests of the western powers and the obstruction of Japan made all of these go for naught, thereby resulting in the outbreak of the March 1st and May 4th Movements. In the face of common enemies and common destiny, the Koreans and Chinese supported each other. The newspaper and magazines in many parts of China, such as Shanghai and Beijing, have made headlines on the news of March 1st Movement and expressed solidarity with Koreans. Two months later, the May 4th Movement broke out in China, and many Koreans not only supported it, but also directly participated in it. The March 1st and May 4th Movements became direct opportunities to reverse the trend of the Korean and Chinese history. After the cruel repression of March 1st Movement by the Governor's Office of Korea, many South Koreans realized that they could not win the independence of Korea at all by non-violent movement. So, they set up anti-Japanese armed groups in Shanghai and even Manchuria to carry out the independence movement across the Tumen River and the Yalu River. The same was true for China also. After the May 4th Movement was suppressed by the warlords in Beijing, the Chinese abandoned their fantasies of northern warlords and imperialism. They started a new democratic revolution against imperialism and feudalism. Presently, 100 years have passed after the March 1st and May 4th Movements. While commemorating these two far-reaching historical events, we should make a correct summary of them and wait for the new future of the northeast Asia.

/ 66

Filters

º¸±âÇü½Ä

Á¤·Ä¼ø¼­

Æ÷¸Ë

¸®½ºÆ® ¼ö